Physician profile
John D Lasater
NPI 1083659007
$1,350.70
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $185 · 2021: $271 · 2023: $51.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $394.91 | 2019-2021 | |
| Pfizer INC. | $163.21 | 2019-2020 | |
| Clarus Therapeutics INC. | $152.84 | 2021 | |
| Janssen Biotech, INC. | $125.00 | 2019 | |
| Endo Pharmaceuticals INC. | $77.72 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $60.51 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $51.03 | 2023 | Bard Urinary Drainage Bag |
| Coloplast Corp | $48.14 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.70 | 2019 | |
| Boston Scientific Corporation | $36.35 | 2019-2020 | |
| Allergan, INC. | $34.46 | 2019 | |
| Amgen INC. | $32.11 | 2019-2021 | |
| Aytu Biopharma, INC. | $22.68 | 2019 | |
| Teleflex LLC | $19.97 | 2021 | |
| Antares Pharma, INC. | $16.45 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih INC. | $15.46 | 2020 | |
| Olympus America INC. | $15.45 | 2020 | |
| Sun Pharmaceutical Industries INC. | $13.14 | 2019 | |
| Metuchen Pharmaceuticals | $12.81 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.76 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$637,739.29 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lasater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.